Answers are grounded in this paper and cite their sources.
Irpex lacteus is a fungus that produces bioactive polysaccharides. In this study, the extraction of a crude Irpex lacteus polysaccharide-rich preparation (ILP) was optimized using response surface methodology (RSM) and a backpropagation neural network–genetic algorithm (BPNN–GA). The BPNN–GA-derived conditions, a liquid–solid ratio of 21 mL/g, extraction time of 3.2 h per cycle, temperature of 87 °C, and two extraction cycles, produced an ILP preparation yield of 5.31%. The carbohydrate fraction of ILP was composed mainly of glucose, galactose, and mannose. ILP exhibited predominantly an amorphous porous morphology, good thermal stability, and concentration-dependent DPPH and hydroxyl radical-scavenging activity. In LPS-stimulated RAW264.7 macrophages, ILP reduced intracellular ROS accumulation and malondialdehyde levels while restoring the activities of superoxide dismutase, catalase, and glutathione peroxidase. In a Caco-2/HT29-MTX-E12/RAW264.7 triple-culture model, ILP treatment increased transepithelial electrical resistance (TEER), reduced the basolateral-to-apical FITC-dextran fluorescence ratio, and altered the expression of mucus-associated markers, including ATOH1, MUC2, TFF3, and RETNLB. These effects were accompanied by lower TNF-α and IL-8 levels and changes in toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/nuclear factor kappa B (NF-κB)-related markers. Collectively, these preliminary in vitro findings suggest that ILP may alleviate LPS-associated oxidative stress and inflammatory responses while supporting epithelial barrier function, highlighting its potential as a fungal-derived functional ingredient for intestinal health.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: